Quick jump to page content
  • Main Navigation
  • Main Content
  • Sidebar
  • Register
  • Login
##common.pageHeaderLogo.altText##
  • Home
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Current
  • Archives
  • Submission

Search

Advanced filters

Search Results

Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: combined results from two phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2)

Andrew Blauvelt, Anderas Wollenberg, Andrew Pink, Ketty Peris, April Armstrong , Lynda Spelman, Hidehisa Saeki, Charles Lynde, Pedro Herranz, Sebastien Barbarot, Eric Simpson

Page s57

Poster PDF

Efficacy and Safety of Tralokinumab Monotherapy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Two 52-Week, Phase 3 Trials (ECZTRA 1 and ECZTRA 2)

Eric Simpson, Andrew Blauvelt, Emma Guttman-Yassky, Margitta Worm, Charles Lynde, Hidehisa Saeki, Yves Poulin, Andreas Wollenberg

Page s96

Poster PDF

Tralokinumab Monotherapy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Regional Differences in Baseline Disease Characteristics and Prior Treatment in the ECZTRA 1 and ECZTRA 2 Trials

Eric Simpson, Thomas Werfel, Thomas Bieber, Louise Steffensen, Alexandra Kuznetsova, Marie ?sterdal, Hidehisa Saeki

Page s101

Poster PDF
1 - 3 of 3 items

 

 

 

 

180x77

Make a Submission

SKIN is a bi-monthly, peer-reviewed, online medical journal dedicated to providing an enhanced route to disseminate new dermatologic knowledge on all aspects of cutaneous disease. The Journal is Open Access. ISSN: 2574-1624

Important Links

  • About the Journal
  • Editorial Team
  • Submissions
  • Contact

Contact

  • Email: jofskin@gmail.com
  • Website: www.jofskin.org
  • Mailing Address: PO Box 569 Millwood NY 10546
OJS Hosting, Support, and Customization by: OpenJournalSystems.com

Modal Header